dr. cohen discusses the keynote-040 trial in head and neck cancer
Published 7 years ago • 228 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
4:03
keynote-040: groundbreaking results for pembrolizumab in head and neck cancer
-
1:36
dr. cohen on immunotherapeutic advances in head and neck cancer
-
1:59
dr. cohen discusses immunotherapy combinations in head and neck cancer
-
1:48
post hoc keynote-040 analysis: pembrolizumab for hnscc produces lasting immune effect
-
1:59
dr. cohen discusses promise of immunotherapy in head and neck cancer
-
1:43
dr. cohen on the quality of life in head and neck cancer
-
3:35
is there a use for anti-pdl-1 antibodies in recurrent head and neck cancer?
-
19:13
gru pet tumor board: case #2
-
1:46
dr. cohen discusses research questions in head and neck cancer
-
1:33
dr. cohen on the era before immunotherapy in head and neck cancer
-
2:05
dr. cohen discusses head and neck cancer pathways
-
1:59
dr. cohen discusses nk-directed therapy in head and neck cancer
-
2:07
dr. cohen on challenges with immunotherapy in head and neck cancer
-
5:34
pembrolizumab for recurrent hnscc
-
1:32
dr. cohen on immunotherapy combinations in head and neck cancer
-
0:55
dr. cohen on immunotherapy in head and neck squamous cell carcinoma
-
1:08
dr. cohen discusses new data on immunotherapies for head and neck cancers
-
2:08
dr. cohen discusses immunotherapy in head and neck cancer
-
6:08
biology of head and neck cancer